购物车
400-168-0010
- 您的位置：
- 快3网下载安装到手机 >>
- 全部标准分类 >>
- 国际标准 >>
- 11.100.20 >>
- ISO 20776-1:2019 EN b26acfa3 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
【国际标准】 Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
本网站 发布时间：
2025-02-18
开通会员免费在线看70000余条国内标准，赠送文本下载次数，单本最低仅合13.3元！还可享标准出版进度查询、定制跟踪推送、标准查新等超多特权！
查看详情>>
标准简介适用范围：
暂无
标准号：
ISO 20776-1:2019 EN
标准名称：
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
英文名称：
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases标准状态：
现行-
发布日期：
2019-06-05 -
实施日期：
出版语种：
EN
- 其它标准
- 上一篇： ISO 20776-1:2006 EN c146ac34 Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
- 下一篇： ISO 20776-2:2007 EN d5a724cc Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices
- 推荐标准
- ISO 10993-10:2021 EN 413c9289 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
- ISO 10993-12:2021 EN 5e177304 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
- ISO 10993-14:2001 EN ce434a96 Biological evaluation of medical devices — Part 14: Identification and quantification of degradation products from ceramics
- ISO 10993-16:2017 EN 38ed29c1 Biological evaluation of medical devices — Part 16: Toxicokinetic study design for degradation products and leachables
- ISO 10993-2:2022 EN c3f97179 Biological evaluation of medical devices — Part 2: Animal welfare requirements
- ISO 10993-3:2014 EN 425b441a Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- ISO 10993-4:2017/Amd 1:2025 EN 0703da00 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1
- ISO 10993-5:2009 EN 6c223ab3 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- ISO 10993-6:2016 EN fe81a910 Biological evaluation of medical devices — Part 6: Tests for local effects after implantation
- ISO 10993-7:2008/Amd 1:2019 EN c85c0ba8 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals — Amendment 1: Applicability of allowable limits for neonates and infants
- ISO 13022:2012 EN c8942a05 Medical products containing viable human cells — Application of risk management and requirements for processing practices
- ISO/TR 10993-33:2015 EN 6f7b2c13 Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3
- ISO/TR 21582:2021 EN 9bf5667f Pyrogenicity — Principles and methods for pyrogen testing of medical devices
- ISO/TR 22442-4:2010 EN 2bd3cadb Medical devices utilizing animal tissues and their derivatives — Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes
- ISO/TS 10993-20:2006 EN 8615a9d6 Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices
